In the present study, we aimed to in vitro evaluate the anti-fibrotic and anti-inflammatory effects of the Hylach compounds in control and IPF human fibroblasts stimulated with TGF-β in the presence or absence of HA or of Hylach with different percentages of lactosylation. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.